Literature DB >> 3759589

Radiotherapy of brain metastases.

S Egawa, I Tukiyama, Y Akine, Y Kajiura, S Yanagawa, K Watai, K Nomura.   

Abstract

The effect of radiotherapy in 254 cases of brain metastases, treated between 1977 and 1984, were studied. The cases included 141 of lung cancer, 28 of mammary cancer, and 85 of other primary sites. The percentages of patients with improvement in clinical symptoms were 8, 39, and 66, respectively. These were groups of patients irradiated with less than 30 Gy, 30 Gy to 50 Gy, and more than 50 Gy. The 50% survival periods from the start of irradiation for the last group were as follows: for radiotherapy only, 4.1 months, radiotherapy and surgery, 4.2 months, radiotherapy and chemotherapy combined, 6.9 months, radiotherapy, surgery and chemotherapy combined, 12.1 months. The intervals between the initial diagnosis and brain metastases were different in lung cancer and mammary cancer, but the prognosis after brain metastases showed little difference between them.

Entities:  

Mesh:

Year:  1986        PMID: 3759589     DOI: 10.1016/0360-3016(86)90288-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  The prognostic factors of lung cancer patients with brain metastases treated with radiotherapy.

Authors:  C Y Hsiung; S W Leung; C J Wang; S K Lo; H C Chen; L M Sun; F M Fang
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

2.  Ten years disease-free survival after solitary brain metastasis from breast cancer.

Authors:  C Nieder; K Walter; U Nestle; K Schnabel
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional study.

Authors:  Nathalie Casanova; Zohra Mazouni; Sabine Bieri; Christophe Combescure; Alessia Pica; Damien C Weber
Journal:  Radiat Oncol       Date:  2010-02-18       Impact factor: 3.481

4.  Phase II study of lonidamine plus radiotherapy in the treatment of brain metastases.

Authors:  D J Stewart; L Eapen; A Girard; S Verma; P Genest; W K Evans
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

5.  Multiple brain metastases: a surgical series and neurosurgical perspective.

Authors:  Maurizio Salvati; Maria Pia Tropeano; Vincenza Maiola; Laura Lavalle; Christian Brogna; Claudio Colonnese; Alessandro Frati; Alessandro D'Elia
Journal:  Neurol Sci       Date:  2018-01-30       Impact factor: 3.307

6.  Management of Brain Metastases.

Authors:  Suriya A. Jeyapalan; Tracy Batchelor
Journal:  Curr Treat Options Neurol       Date:  2004-07       Impact factor: 3.598

7.  The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors.

Authors:  Thomas L Ellis; Matthew T Neal; Michael D Chan
Journal:  Int J Surg Oncol       Date:  2011-10-16

8.  Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases.

Authors:  B Stea; E Shaw; T Pintér; J Hackman; M Craig; J May; R P Steffen; J H Suh
Journal:  Br J Cancer       Date:  2006-06-19       Impact factor: 7.640

Review 9.  The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Mark E Linskey; David W Andrews; Anthony L Asher; Stuart H Burri; Douglas Kondziolka; Paula D Robinson; Mario Ammirati; Charles S Cobbs; Laurie E Gaspar; Jay S Loeffler; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Roy A Patchell; Timothy C Ryken; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

10.  The role of surgical resection in patients with brain metastases.

Authors:  Mustafa Aziz Hatiboglu; David M Wildrick; Raymond Sawaya
Journal:  Ecancermedicalscience       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.